SG11201806422XA - Compositions comprising choline and their use - Google Patents

Compositions comprising choline and their use

Info

Publication number
SG11201806422XA
SG11201806422XA SG11201806422XA SG11201806422XA SG11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA
Authority
SG
Singapore
Prior art keywords
march
international
pct
rule
applicant
Prior art date
Application number
SG11201806422XA
Inventor
Nora Schneider
Jonas Hauser
Zolezzi Irma Silva
Tinu Samuel
Sean Deoni
Tamas Bartfai
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of SG11201806422XA publication Critical patent/SG11201806422XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/167895 Al 5 October 2017 (05.10.2017) WIPO I PCT 111111111111110111011111111111010111110 0111100111111101111111111111111110111111 (51) (21) International Patent Classification: A61K 31/14 (2006.01) A61P 25/00 (2006.01) International Application Number: PCT/EP2017/057571 (22) International Filing Date: 30 March 2017 (30.03.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/315,134 30 March 2016 (30.03.2016) US 62/315,142 30 March 2016 (30.03.2016) US 62/315,152 30 March 2016 (30.03.2016) US 62/315,158 30 March 2016 (30.03.2016) US 62/315,163 30 March 2016 (30.03.2016) US 62/328,105 27 April 2016 (27.04.2016) US PCT/EP2016/080790 13 December 2016 (13.12.2016) EP (71) Applicant: NESTEC S.A. [CH/CH]; Avenue Nestle 55, 1800 VEVEY (CH). (72) Inventors: SCHNEIDER, Nora; 31, Rte de la Croix- Blanche, 1066 Epalinges (CH). HAUSER, Jonas; 39, Rue de l'Ale, 1003 Lausanne (CH). SILVA ZOLEZZI, Irma; 5, Chemin de la Fontanettaz, 1084 Carrouge (CH). SAMUEL, Tinu, Mary; 98, Le Grand Chemin, 1066 Epalinges (CH). DEONI, Sean; Brown University, Divi- sion of Engineering, Providence, Rhode Island 02912 (US). BARTFAI, Tamas; 32, Upplandsgatan, 11328 Stockholm (SE). (74) Agent: NAUDE, Dawn; Nestle Research Center, Vers- chez-les-Blanc, 1000 Lausanne 26 (CH). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) of inventorship (Rule 4.17(iv)) Published: with international search report (Art. 21(3)) W O 20 17 / 167 895 Al (54) Title: COMPOSITIONS COMPRISING CHOLINE AND THEIR USE (57) : The present invention relates to a composition comprising choline for use in promoting, supporting or optimizing one or more of the following: (i) de novo myelination; (ii) brain structure; (iii) brain connectivity; (iv) intellectual potential; (v) cognitive potential; (vi) learning potential; and (vi) cognitive function; in an offspring of a female subject, wherein said composition is for ad- ministration to the female subject.
SG11201806422XA 2016-03-30 2017-03-30 Compositions comprising choline and their use SG11201806422XA (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201662315142P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315152P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662315163P 2016-03-30 2016-03-30
US201662328105P 2016-04-27 2016-04-27
PCT/EP2016/080790 WO2017167417A1 (en) 2016-03-30 2016-12-13 Compositions comprising choline and their use
PCT/EP2017/057571 WO2017167895A1 (en) 2016-03-30 2017-03-30 Compositions comprising choline and their use

Publications (1)

Publication Number Publication Date
SG11201806422XA true SG11201806422XA (en) 2018-10-30

Family

ID=57758563

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201803026RA SG11201803026RA (en) 2016-03-30 2016-12-13 Compositions comprising choline and their use
SG11201806422XA SG11201806422XA (en) 2016-03-30 2017-03-30 Compositions comprising choline and their use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201803026RA SG11201803026RA (en) 2016-03-30 2016-12-13 Compositions comprising choline and their use

Country Status (8)

Country Link
EP (1) EP3435991A1 (en)
CN (2) CN108697671A (en)
BR (2) BR112018011394A2 (en)
CA (2) CA3003656A1 (en)
MX (3) MX2018008518A (en)
PH (1) PH12018501782A1 (en)
SG (2) SG11201803026RA (en)
WO (2) WO2017167417A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201900604TA (en) * 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Pre-natal beta-cryptoxanthin benefits children
US20210353566A1 (en) * 2020-05-12 2021-11-18 Massachusetts Institute Of Technology The use of choline supplementation as therapy for apoe4-related disorders
CN112655969A (en) * 2021-03-15 2021-04-16 江苏艾兰得营养品有限公司 Choline bitartrate granules, tablets containing same and preparation method
WO2024038010A1 (en) 2022-08-18 2024-02-22 Société des Produits Nestlé S.A. Kit to promote developmental myelination

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322589B1 (en) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Process for the preparation of a lactoserum protein hydrolysate and a hypoallergenic food
EP0880902A1 (en) 1997-05-27 1998-12-02 Nestlé Produkte AG Process for treating a raw whey material
WO1999063943A2 (en) * 1998-06-12 1999-12-16 Craig Anthony Cooney Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
RU2275041C2 (en) 1999-04-29 2006-04-27 Сосьете Де Продюи Нестле С.А. Composition of milk mixture, method for producing the same and milk mixture including composition (versions)
CN1778199A (en) * 2004-11-24 2006-05-31 王维义 Nutrient for pregnant woman and delivery woman
RU2480474C2 (en) * 2005-04-28 2013-04-27 Энзимотек Лтд. Mixtures of polar lipids, production and use thereof
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2258218A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258217A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
ITGE20110050A1 (en) * 2011-04-29 2012-10-30 Marco Zipoli FOOD, IN PARTICULAR A DRINK FOR HUMAN CONSUMPTION
BR122022002021B1 (en) * 2015-12-14 2023-03-14 Société des Produits Nestlé S.A. SYNTHETIC NUTRITIONAL COMPOSITION, ITS USE AND MINERAL
BR112018010278A2 (en) * 2015-12-14 2018-11-27 Nestec Sa nutritional compositions and baby formulas to promote myelination in the brain
BR112018011835A2 (en) * 2015-12-14 2018-11-27 Nestec Sa nutritional compositions and baby formulas to promote myelination in the brain

Also Published As

Publication number Publication date
MX2018008518A (en) 2018-08-16
CN108697671A (en) 2018-10-23
BR112018011394A2 (en) 2018-12-04
CN108697672A (en) 2018-10-23
EP3435991A1 (en) 2019-02-06
MX2022012236A (en) 2023-01-24
SG11201803026RA (en) 2018-05-30
PH12018501782A1 (en) 2019-06-17
WO2017167417A1 (en) 2017-10-05
BR112018067423A2 (en) 2019-01-22
CA3017842A1 (en) 2017-10-05
MX2018011680A (en) 2019-01-10
CA3003656A1 (en) 2017-10-05
WO2017167895A1 (en) 2017-10-05

Similar Documents

Publication Publication Date Title
SG11201806545WA (en) Compositions comprising fatty acids and their use
SG11201807195VA (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
SG11201805044WA (en) Compounds useful as kinase inhibitors
SG11201810571RA (en) Compositions comprising bacterial strains
SG11201811491YA (en) Quinazoline and indole compounds to treat medical disorders
SG11201804373VA (en) Compositions and methods for immunooncology
SG11201804211YA (en) Compositions comprising bacterial strains
SG11201804118VA (en) Compositions comprising bacterial strains
SG11201811564QA (en) Methods of treating ovarian cancer
SG11201804510PA (en) Biparatopic polypeptides antagonizing wnt signaling in tumor cells
SG11201805311XA (en) Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
SG11201805001UA (en) Method of treating influenza a
SG11201806422XA (en) Compositions comprising choline and their use
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201808566WA (en) Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201807041PA (en) Improved preparations of adult liver progenitor cells
SG11201806431RA (en) Compositions comprising minerals and their use
SG11201806434XA (en) Compositions comprising phospholipid and their use
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11201804704PA (en) Compositions and methods for decreasing tau expression
SG11201807523PA (en) Ilt7 binding molecules and methods of using the same
SG11201808686VA (en) Synthesis of indazoles
SG11201807915QA (en) Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
SG11201809630RA (en) Nicotine particles